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Guest Editorial 1 
 2 
Canine insulinoma as a model for studying molecular genetics of tumorigenesis 3 
and metastasis 4 
 5 
Insulinoma is the most frequently diagnosed neuroendocrine pancreatic tumor of 6 
dogs and humans. Most insulinomas of humans are treated effectively by surgical 7 
excision. However, a subset of human insulinomas exhibits cellular characteristics and 8 
clinical behavior consistent with malignancy and these are referred to as ‘malignant 9 
insulinoma’. Tumors of the latter type are therapeutically challenging and difficulties 10 
are magnified because surgical excision of malignant insulinoma is rarely complete and 11 
recurrence is likely, features which conspire to decrease survival times in affected 12 
patients. 13 
 14 
In the dog, the biologic course of insulinoma resembles that of malignant 15 
insulinoma in humans. Morbidity in dogs with insulinoma is usually due to the 16 
functional capacity of the tumor rather than signs related to its physical presence. Until 17 
hypoglycemia becomes apparent, the tumor with its high metastatic potential may elude 18 
diagnosis. In the dog, as in humans, surgery along with post-operative chemotherapy is 19 
still the recommended approach when possible. Despite the recent observation that 20 
intensive management improves survival times (Polton et al., 2007), the high prevalence 21 
of distant metastasis at diagnosis limits therapeutic options and translates to a poor long 22 
term prognosis for affected dogs. Novel approaches are needed to improve diagnosis, 23 
prognosis and therapy for canine and human insulinomas. 24 
 25 
Despite the clinical challenges associated with definitive treatment of canine 26 
insulinoma, it is a well defined tumor syndrome that offers excellent opportunities for 27 
molecular study of basic tumor biology. A series of recent papers by Dr Floryne 28 
Buishand and colleagues of Utrecht and Maastricht Universities, including the study 29 
that appears in this issue of Veterinary Journal (Buishand et al., 2013), both contribute 30 
to our understanding of the molecular genetics of canine insulinoma and serve to 31 
highlight the use of canine insulinoma as a valuable research model for the study of 32 
tumorigenesis and metastasis. 33 
 34 
Insulinomas in humans can occur as part of an inherited syndrome, designated 35 
multiple endocrine neoplasm type 1 (MEN1), but the majority of human insulinomas 36 
arise sporadically and are due to an inherited genetic mutation (Jonkers et al., 2007). 37 
Although there are reports of MEN-like syndromes in dogs, including one dog with an 38 
insulinoma (Kiupel et al., 2000), the role of MEN1, the gene responsible for the MEN 39 
syndrome, has not yet been investigated in canine insulinoma. However, no MEN1 40 
coding mutations were found in a study of Keeshonds with familial 41 
hyperparathyroidism (Skelly and Franklin, 2007). As in humans, the majority of 42 
insulinomas occurring in dogs are considered to be ‘sporadic’. The genetic alterations in 43 
sporadic tumors are caused by somatic mutations, but the precise genes and the 44 
molecular mechanisms involved that promote unrestrained cell growth and metastasis 45 
remain poorly defined. 46 
 47 
Microarray studies of human insulinomas have revealed changes in expression 48 
of genes involved in DNA repair, apoptosis and transcriptional regulation pathways 49 
(Jonkers et al., 2007). In this issue, Buishand et al. (2013) used microarray analysis to 50 
investigate the expression of a large number of genes (>10,000) in primary canine 51 
insulinomas and their metastases. Pathway analysis revealed down-regulation of 52 
pathways involved in DNA damage repair, including breast cancer type 1 (BRCA1), 53 
which is also abnormal in some human insulinomas, and pathways involved in cell 54 
cycle regulation, including the ataxia telangiectasia mutated and Rad3-related 55 
(ATM/ATR) pathway, which regulates entry into the cell cycle S phase. Substantial 56 
differences in gene expression were also noted between primary insulinomas and their 57 
corresponding metastases. Interestingly, a similar study of human insulinomas did not 58 
find differences in gene expression profiles when primary insulinomas and their 59 
metastasis were compared (Capurso et al., 2006). 60 
 61 
Several other features of canine insulinomas identified by Buishand and 62 
colleagues, such as expression of growth hormone (Buishand et al., 2012) and, in the 63 
current study, co-expression of genes typically expressed in the exocrine pancreas 64 
(Buishand et al., 2013), are not frequently observed in human insulinomas or have not 65 
yet been fully investigated (Wulbrand et al., 2000; Ordonez, 2001). 66 
 67 
It is safe to assert that new targets for insulinoma therapy may be identified by 68 
uncovering the pathways that permit unregulated growth and that facilitate distant 69 
metastasis of tumor cells. While extrapolation of knowledge from human studies is 70 
often the source of new approaches in veterinary medicine, the highlighted differences 71 
between canine and human insulinoma emphasize the need for focused studies of canine 72 
tumors. The work of Buishand and colleagues represents an important step forward in 73 
understanding the molecular genetics of canine insulinoma, particularly how these 74 
mechanisms dictate tumor growth and metastasis. 75 
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